Style | Citing Format |
---|---|
MLA | Daneshmand B, et al.. "Application of Disaccharides Alone and in Combination, for the Improvement of Stability and Particle Properties of Spray-Freeze Dried Igg." Pharmaceutical Development and Technology, vol. 24, no. 4, 2019, pp. 439-447. |
APA | Daneshmand B, Faghihi H, Amini Pouya M, Aghababaie S, Darabi M, Vatanara A (2019). Application of Disaccharides Alone and in Combination, for the Improvement of Stability and Particle Properties of Spray-Freeze Dried Igg. Pharmaceutical Development and Technology, 24(4), 439-447. |
Chicago | Daneshmand B, Faghihi H, Amini Pouya M, Aghababaie S, Darabi M, Vatanara A. "Application of Disaccharides Alone and in Combination, for the Improvement of Stability and Particle Properties of Spray-Freeze Dried Igg." Pharmaceutical Development and Technology 24, no. 4 (2019): 439-447. |
Harvard | Daneshmand B et al. (2019) 'Application of Disaccharides Alone and in Combination, for the Improvement of Stability and Particle Properties of Spray-Freeze Dried Igg', Pharmaceutical Development and Technology, 24(4), pp. 439-447. |
Vancouver | Daneshmand B, Faghihi H, Amini Pouya M, Aghababaie S, Darabi M, Vatanara A. Application of Disaccharides Alone and in Combination, for the Improvement of Stability and Particle Properties of Spray-Freeze Dried Igg. Pharmaceutical Development and Technology. 2019;24(4):439-447. |
BibTex | @article{ author = {Daneshmand B and Faghihi H and Amini Pouya M and Aghababaie S and Darabi M and Vatanara A}, title = {Application of Disaccharides Alone and in Combination, for the Improvement of Stability and Particle Properties of Spray-Freeze Dried Igg}, journal = {Pharmaceutical Development and Technology}, volume = {24}, number = {4}, pages = {439-447}, year = {2019} } |
RIS | TY - JOUR AU - Daneshmand B AU - Faghihi H AU - Amini Pouya M AU - Aghababaie S AU - Darabi M AU - Vatanara A TI - Application of Disaccharides Alone and in Combination, for the Improvement of Stability and Particle Properties of Spray-Freeze Dried Igg JO - Pharmaceutical Development and Technology VL - 24 IS - 4 SP - 439 EP - 447 PY - 2019 ER - |